- Amazon has cancelled its application for a pharmaceutical wholesaler license in Maine.
- The cancellation could have big implications for Amazon's potential ambitions in healthcare.
- "We see this cancellation as a negative indicator of the likelihood that Amazon enters pharmacy in the near term and thus as a positive for the pharmacies and drug supply chain," analysts at RBC Capital Markets wrote in a note.
ADVERTISEMENT
Amazon could have dropped a big hint that it's not going to start selling prescription drugs (AMZN)
Amazon has cancelled its application for a pharmaceutical wholesaler license in Maine.
Amazon has cancelled an application for wholesale pharmacy licenses in the state of Maine.
The cancellation, which Business Insider first spotted in a note from RBC Capital Markets and confirmed via the Maine Board of Pharmacy's website, occurred on December 1 and could have big implications for Amazon's potential ambitions in healthcare.
In October, the St. Louis Post-Dispatch
JOIN OUR PULSE COMMUNITY!
ADVERTISEMENT
Eyewitness? Submit your stories now via social or:
Email: eyewitness@pulse.ng
ADVERTISEMENT